• <nav id="y8qoo"><strong id="y8qoo"></strong></nav>
  • <menu id="y8qoo"><strong id="y8qoo"></strong></menu>
  • LINE

    Text:AAAPrint
    Society

    China approves clinical trials for CanSino's inhaled COVID-19 vaccine

    1
    2021-03-26 10:02:07Xinhua Editor : Li Yan ECNS App Download
    A container of the active substance needed to make a COVID-19 vaccine is seen at the Mexico City International Airport in Mexico City, Mexico, Feb. 11, 2021. (Xinhua)

    A container of the active substance needed to make a COVID-19 vaccine is seen at the Mexico City International Airport in Mexico City, Mexico, Feb. 11, 2021. (Xinhua)

    Special: Battle Against Novel Coronavirus

    China's drug authority has approved clinical tests for an inhaled COVID-19 vaccine co-developed by domestic company CanSino Biologics, the Agence France-Presse (AFP) reported on Tuesday.

    The clinical trial application of the vaccine, jointly developed by CanSino and the Beijing Institute of Biotechnology, was approved by the National Medical Products Administration (NMPA) on Monday, the pharmaceutical firm said in a filing on the Hong Kong stock exchange on Tuesday.

    The safety and efficacy of the inhaled vaccine remain "subject to confirmation," the firm said.

    The NMPA conditionally approved a recombinant vaccine for COVID-19 made by CanSino last month, which marked the first approved adenoviral vector vaccine for COVID-19.

    More than 85.85 million doses of COVID-19 vaccines have been administered across China as of Wednesday, the National Health Commission said Thursday.

    MorePhoto

    Most popular in 24h

    MoreTop news

    MoreVideo

    LINE
    Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
    Copyright ©1999-2021 Chinanews.com. All rights reserved.
    Reproduction in whole or in part without permission is prohibited.
    女性二十四种b型图_深田えいみ在线无码播放观看_学生刚刚发育的小馒头露出来_欧美在线看欧美视频免费_揉胸视频_日本年轻的继坶5中字